ReShape Lifesciences
ReShape Lifesciences (formerly ReShape Medical) is a Minnesota-based medical weight management company that occupies a niche no other telehealth platform does: combining an FDA-cleared intragastric balloon procedure with telehealth-based GLP-1 medication management. Founded around 2012 as a device company focused on the non-surgical ReShape Balloon, the company has evolved its model over time to include pharmaceutical weight management alongside its procedural offerings.
Overview
- Consultation Model
- Hybrid
- Headquarters
- Eden Prairie, MN
- Shipping
- 3-5 business days
- Lab Testing
- No
- Prescriber Info
- licensed physicians are authorized to prescribe.
- Founded
- 2012
Pros
- Only platform combining telehealth GLP-1 prescribing with an FDA-cleared intragastric balloon option
- Procedural track appeals to patients who prefer a device-based intervention over daily or weekly injections
- Balloon option does not require general anesthesia and is reversible
Cons
- Intragastric balloon procedures cost $3,000–$9,000+ and are rarely covered by insurance
- Smaller platform with limited independent reviews and less public transparency than major GLP-1 telehealth companies
- GLP-1 telehealth program availability and details are difficult to verify independently
- Geographic availability for balloon procedures is limited to affiliated surgical centers